Walid Kamoun: Breakthroughs Begin With the Right Questions and the Courage to Pursue Them
oncodaily - Walid Kamoun, Vice President, Global Head of R/D Oncology at Servier, shared The Nobel Prize’s post on LinkedIn, adding: “In this inspiring video, Tasuku Honjo reminds us that breakthrough innovation […]
AI Summary: Health officials confirmed a second fatality tied to a Legionnaires' disease outbreak in New York City, prompting intensified environmental testing and public‑health interventions. Authorities are tracing sources, inspecting water systems and issuing guidance to vulnerable populations while hospitals manage a surge of severe respiratory infections.
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
Christina Jewett and Dana G. Smith / nytimes - Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.
AI Summary: Federal regulators have zeroed in on a set of peptide injections gaining traction among wellness influencers and endorsed by RFK Jr., prompting internal debates about safety, evidence and regulation. FDA scientists are reviewing the products' claims and potential risks, setting up a clash between celebrity-driven demand and the agency’s evidence-based caution.
- Advisory panel votes to expand compounding despite safety warnings (4)
- FDA review and RFK Jr. clash over influencer‑favored peptides (4)
- Market hype and regulation: guidances, reporting and uncertainty (5)